Role of CD14 in responses to clinical isolates of Escherichia coli: Effects of K1 capsule expression

Infection and Immunity

Volumn 75, Issue 11, 2007, Pages 5415-5424

  Metkar, Shalaka ^a   Awasthi, Shanjana ^b,e   Denamur, Erick ^c   Kwang, Sik Kim ^d   Gangloff, Sophie C ^b,f   Teichberg, Saul ^b   Haziot, Alain ^b,g   Silver, Jack ^a   Goyert, Sanna M ^a  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c INSERM   (France)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^g Inst Natl S et de la Rech U129   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; INFECTION RESISTANCE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STRAIN DIFFERENCE;

ANIMAL STRUCTURES; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD14; BACTERIAL CAPSULES; COLONY COUNT, MICROBIAL; DISEASE SUSCEPTIBILITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE DELETION; IMMUNITY, NATURAL; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; POLYSACCHARIDES, BACTERIAL; SEPSIS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35649028439     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00601-07     Document Type: Article

References (50)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-874.
2. Bernheiden, M., J. M. Heinrich, G. Minigo, C. Schutt, F. Stelter, M. Freeman, D. Golenbock, and R. S. Jack. 2001. LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection. J. Endotoxin Res. 7:447-450.
3. Bliss, J. M., and R. P. Silver. 1996. Coating the surface: a model for expression of capsular polysialic acid in Escherichia coli K1. Mol. Microbiol. 21:221-231.
4. Bone, R. C., C. L. Sprung, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure. Crit. Care Med. 20:724-726.
5. Cross, A., L. Asher, M. Seguin, L. Yuan, N. Kelly, C. Hammack, J. Sadoff, and P. Gemski, Jr. 1995. The importance of a lipopolysaccharide- initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J. Clin. Investig. 96:676-686.
6. Cross, A. S., J. C. Sadoff, N. Kelly, E. Bernton, and P. Gemski. 1989. Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection. J. Exp. Med. 169:2021-2027.
7. Cross, A. S. 1990. The biologic significance of bacterial encapsulation. Curr. Top. Microbiol. Immunol. 150:87-95.
8. Damas, P., A. Reuter, P. Geysen, J. Demonty, M. Lamy, and P. Franchimont. 1989. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17:975-978.
9. Ferrero, E., C. L. Hsieh, U. Francke, and S. M. Goyert. 1990. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol. 145:331-336.
10. Ferrero, E., D. Jiao, B. Z. Tsuberi, L. Tesio, G. W. Rong, A. Haziot, and S. M. Goyert. 1993. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:2380-2384.
11. Fitzgerald, K. A., D. C. Rowe, and D. T. Golenbock. 2004. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect. 6:1361-1367.
12. Frevert, C. W., G. Matute-Bello, S. J. Skerrett, R. B. Goodman, O. Kajikawa, C. Sittipunt, and T. R. Martin. 2000. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J. Immunol. 164:5439-5445.
13. Gangloff, S. C., U. Zahringer, C. Blondin, M. Guenounou, J. Silver, and S. M. Goyert. 2005. Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex. J. Immunol. 175:3940-3945.
14. Gangloff, S. C., N. Hijiya, A. Haziot, and S. M. Goyert. 1999. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. Clin. Infect. Dis. 28:491-496.
15. Goyert, S. M., E. Ferrero, W. J. Rettig, A. K. Yenamandra, F. Obata, and M. M. Le Beau. 1988. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239:497-500.
16. Grone, A. 2002. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88:1-12.
17. Haziot, A., S. Chen, E. Ferrero, M. G. Low, R. Silber, and S. M. Goyert. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:547-552.
18. Haziot, A., B.-Z. Tsuberi, and S. M. Goyert. 1993. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-α in response to lipopolysaccharide. J. Immunol. 150:5556-5565.
19. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-414.
20. Horn, D. L., D. C. Morrison, S. M. Opal, R. Silverstein, K. Visvanathan, and J. B. Zabriskie. 2000. What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium. Clin. Infect. Dis. 31:851-858.
21. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.
22. Kim, K. J., S. J. Elliott, F. Di Cello, M. F. Stins, and K. S. Kim. 2003. The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells. Cell. Microbiol. 5:245-252.
23. Knuefermann, P., S. Nemoto, A. Misra, N. Nozaki, G. Defreitas, S. M. Goyert, B. A. Carabello, D. L. Mann, and J. G. Vallejo. 2002. CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. Circulation 106:2608-2615.
24. Leturcq, D. J., A. M. Moriarty, G. Talbott, R. K. Winn, T. R. Martin, and R. J. Ulevitch. 1996. Antibodies against CD14 protect primates from endotoxin-induced shock. J. Clin. Investig. 98:1533-1538.
25. Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 29:530-538.
26. Luft, J. H. 1971. Ruthenium red and violet. I. Chemistry, purification, methods of use for electron microscopy and mechanism of action. Anat. Rec. 171:347-368.
27. Mahnke, K., E. Becher, P. Ricciardi-Castagnoli, T. A. Luger, T. Schwarz, and S. Grabbe. 1997. CD14 is expressed by subsets of murine dendritic cells and upregulated by lipopolysaccharide. Exp. Med. Biol. 417:145-159.
28. McCabe, W. R., B. Kaijser, S. Olling, M. Uwaydah, and L. A. Hanson. 1978. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J. Infect. Dis. 138:33-41.
29. Morrison, D. C., and J. L. Ryan. 1987. Endotoxin and disease mechanisms. Annu. Rev. Med. 38:417-432.
30. Opal, S. M., J. E. Palardy, N. Parejo, and R. L. Jasman. 2003. Effect of anti CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia. Crit. Care Med. 31:929-932.
31. Picard, B., J. S. Garcia, S. Gouriou, P. Duriez, N. Brahimi, E. Bingen, J. Elion, and E. Denamur. 1999. The link between phytogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67:546-553.
32. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
33. Raetz, C. R., R. J. Ulevitch, S. D. Wright, C. H. Sibley, A. Ding, and C. F. Nathan. 1991. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 5:2652-2660.
34. Raetz, C. R. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59:129-170.
35. Remick, D. G., G. R. Bolgos, J. Siddiqui, J. Shin, and J. A. Nemzek. 2002. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17:463-467.
36. Remick, D. G., G. Bolgos, S. Copeland, and J. Siddiqui. 2005. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect. Immun. 73:2751-2757.
37. Roberts, I. S. 1996. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 50:285-315.
38. Russo, T. A., G. Sharma, C. R. Brown, and A. A. Campagnari. 1995. Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect. Immun. 63:1263-1269.
39. Schiffer, M. S., E. Oliveira, M. P. Glode, G. H. McCracken, Jr., L. M. Sarff, and J. B. Robbins. 1976. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr. Res. 10:82-87.
40. Schimke, J., J. Mathison, J. Morgiewicz, and R. J. Ulevitch. 1998. Anti CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc. Natl. Acad. Sci. USA 95:13875-13880.
41. Tasaka, S., A. Ishizaka, W. Yamada, M. Shimizu, H. Koh, N. Hasegawa, Y. Adachi, and K. Yamaguchi. 2003. Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. Am. J. Respir. Cell Mol. Biol. 29:252-258.
42. Timmis, K. N., G. J. Boulnois, D. Bitter-Suermann, and F. C. Cabello. 1985. Surface components of Escherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes. Curr. Top. Microbiol. Immunol. 118:197-218.
43. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
44. Turnbull, I. R., P. Javadi, T. G. Buchman, R. S. Hotchkiss, I. E. Karl, and C. M. Coopersmith. 2004. Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels. Shock 21:121-125.
45. Van Amersfoort, E. S., T. J. Van Berkel, and J. Kuiper. 2003. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin. Microbiol. Rev. 16:379-414.
46. Vyas, D., P. Javadi, P. J. Dipasco, T. G. Buchman, R. S. Hotchkiss, and C. M. Coopersmith. 2005. Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289:R1048-R1053.
47. Whitfield, C., and I. S. Roberts. 1999. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol. Microbiol. 31:1307-1319.
48. Woodhead, V. E., M. H. Binks, B. M. Chain, and D. R. Katz. 1998. From sentinel to messenger: an extended phenotypic analysis of the monocyte to dendritic cell transition. Immunology 94:552-559.
49. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
50. Xiao, H., J. Siddiqui, and D. G. Remick. 2006. Mechanisms of mortality in early and late sepsis. Infect. Immun. 74:5227-5235.